Oxygenta Pharmaceutical Limited is an India-based company engaged in the manufacturing and selling of pharmaceutical, medical and veterinary preparations. It operates in the pharmaceutical segment. The Company also sells the products to its related companies engaged in the manufacture of formulations. Its active pharmaceutical ingredients (API) products include pantoprazole sodium, vildagliptin, telmisartan, lacosamide, and sertraline hydrochloride. The Company’s chemical products include 3-Amino-1-adamantanol, (S)-1-(2-Chloroacetyl) pyrrolidine-2-carbonitrile, 2-N-Propyl-4-methyl-6-(1-methyl benzimidazole-2-yl) benzimidazole, Isobutyramide, 4-Aminobenzonitrile, Valeronitrile and others. Its manufacturing facilities are situated at Sadasivapet Mandal, Sangareddy District, Telangana State. As of 26 May 2026, OXYGENTA PHARMACEUTICAL LIMITE share price is ₹50.20. The stock opened at ₹52.60, compared to its previous close of ₹52.60. During today's trading session, OXYGENTA PHARMACEUTICAL LIMITE share price moved in the range of ₹50.20 to ₹53.50, with an average price of ₹51.85 for the day. Looking at its last 52-week, the stock has touched a low of ₹50.20 and a high of ₹53.50.
The market capitalization of OXYGENTA PHARMACEUTICAL LIMITE is ₹195 Crs, with a P/E ratio of -10.8 and a dividend yield of 0.00%.